These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3007886)

  • 1. [Human T-lymphotropic virus (HTLV-III) antibodies in intravenous drug addicts from the Valencia community].
    Rodrigo JM; Serra MA; Aguilar E; Ample I; Gimeno V; del Olmo JA; Escudero A; Aparisi L; Wassel A; Sanmartín B
    Med Clin (Barc); 1986 Jan; 86(3):89-92. PubMed ID: 3007886
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevalence of antibodies against human T-lymphotropic virus type III (HTLV-III) in parenteral drug addicts in the Barcelona area].
    Muga R; Tor J; Argelagués E; Rey-Joly C; Foz M; Ribas-Mundó M
    Med Clin (Barc); 1986 Jan; 86(3):97-9. PubMed ID: 3457230
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunity and drug addiction: immunologic situation in relation to the drug, HTLV-III infection and other associated infections].
    Asensi V; Cartón JA; Fernández-León A; Cárcaba V; Navia-Osorio JM; Pérez R; Diéguez MA; Arribas JM
    Med Clin (Barc); 1986 Jan; 86(3):105-9. PubMed ID: 3007879
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid].
    Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E
    Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analysis of antibodies to human T-lymphotropic type III virus (anti-HTLV III) in a population at high risk for AIDS in Yugoslavia].
    Burek V; Sakoman S; Hudolin V; Kovać D; Ficović P; Cepelja Z; Petricević I; Schönwald S; Soldo I; Borcić D
    Lijec Vjesn; 1987 Jun; 109(6):216-9. PubMed ID: 3477674
    [No Abstract]   [Full Text] [Related]  

  • 6. HTLV-III antibody in intravenous drug abusers of metropolitan Barcelona, Spain.
    Tor J; Muga R; Argelagues E; Rey-Joly C; Foz M; Ribas-Mundó M
    Arch Intern Med; 1986 Apr; 146(4):805. PubMed ID: 3008680
    [No Abstract]   [Full Text] [Related]  

  • 7. [HTLV-III serology, epidemiology and clinical aspects of imprisoned i.v. drug-dependent males in Austria].
    Pont J; Neuwald C; Kunz C; Werdenich W
    Wien Klin Wochenschr; 1986 Jul; 98(14):454-7. PubMed ID: 3019019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
    Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
    Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
    [No Abstract]   [Full Text] [Related]  

  • 9. [HTLV-III infection in risk groups].
    Esteban R; Buti M; Esteban JI; Hernández JM; Jardí R; Vila M; Tusell J; Guardia J
    Med Clin (Barc); 1986 Jan; 86(3):110-2. PubMed ID: 3007880
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevalence of anti-LAV/HTLV-III in prostitutes in Seville].
    Pineda JA; Leal M; García de Pesquera F; Sánchez-Quijano A; Rivera F; Lissen E
    Med Clin (Barc); 1986 Mar; 86(12):498-500. PubMed ID: 3012223
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunological profile of drug addicts: HTLV-III negative, HTLV-III positive and those with lymphadenopathy syndrome-AIDS related complex].
    Cascavilla N; Martini E; Melillo L; Musto P; Nobile M; Valori VM; Di Giorgio G; Carotenuto M
    Recenti Prog Med; 1987 Mar; 78(3):108-12. PubMed ID: 3648856
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural and epidemiological features of primate lymphotropic retroviruses.
    Hunsmann G; Schneider J; Bayer H; Jurkiewicz E; Yamamoto N
    Princess Takamatsu Symp; 1984; 15():109-18. PubMed ID: 6100632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of the determination of anti-HTLV-III antibodies in parenteral drug addicts].
    Forteza-Rei J; Altés J; Villalonga C; Riera M
    Med Clin (Barc); 1986 Apr; 86(14):610. PubMed ID: 3014238
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significance of neopterin, gamma interferon and other immunologic parameters determined in a population of drug addicts, positive or negative for anti-HTLV III antibodies].
    Soffritti E; Dallara G; Bernardoni R; Ferrari R; Pelizzola D; Cicognani I; Gallerani M; Colamussi V; Cazzuffi S; Scaglianti G
    G Clin Med; 1987 Feb; 68(2):87-95. PubMed ID: 3111926
    [No Abstract]   [Full Text] [Related]  

  • 15. [Case reports of 77 HTLV III/LAV-positive patients observed during one-year period. Preliminary note].
    Soranzo ML; Salassa B; Daziano E; Paggi GC
    Minerva Med; 1986 May; 77(20):897-900. PubMed ID: 3014379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A stage model of HTLV-III LAV infection in intravenous drug users.
    Des Jarlais DC; Friedman SR; Spira TJ; Zolla-Pazner S; Marmor M; Holzman R; Mildvan D; Yancovitz S; Mathur-Wagh U; Garber J
    NIDA Res Monogr; 1986; 67():328-34. PubMed ID: 3018574
    [No Abstract]   [Full Text] [Related]  

  • 17. Kaplan memorial lecture. The family of human lymphotropic retroviruses called HTLV: HTLV-I in adult T-cell leukemia (ATL), HTLV-II in hairy cell leukemias, and HTLV-III in AIDS.
    Gallo RC
    Princess Takamatsu Symp; 1984; 15():13-38. PubMed ID: 6100633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T-cell lymphotropic virus type III associated disorders. The spectrum in the heterosexual population.
    Gill PS; Levine AM; Meyer PR; Aguilar SL; Rarick M; Parker JW; Rasheed S
    Arch Intern Med; 1986 Aug; 146(8):1501-4. PubMed ID: 3015064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic abnormalities and antibodies to HTLV-III in asymptomatic drug addicts.
    Ortona L; Laghi V; Tamburrini E; Nervo P; Cauda R
    Ala J Med Sci; 1987 Jan; 24(1):46-51. PubMed ID: 3644604
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombopenic purpura in a group of addicts addicted to parenteral drugs with anti-HTLV-III/LAV antibodies and inversion of the T-helper/T-suppressor cell quotient].
    Aguilar Ligorti E; Guix García J; Ample Guillén I; Balaguer Martínez JV; Marugán de la Concha I; García-Conde Bru J
    Sangre (Barc); 1986; 31(4):401-10. PubMed ID: 2947340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.